文化适应的移动应用程序,以优化1型糖尿病的代谢控制:一个试点研究
Jenny L Cepeda-Marte1, Arelis Moore2, Carlos B Ruiz-Matuk1
1Universidad Iberoamericana Research Hub Santo Domingo Dominican Republic Universidad Iberoamericana, Research Hub, Santo Domingo, Dominican Republic.
概括
一个针对1型糖尿病青少年的文化适应的移动应用程序显著改善了脂质概况和生活质量. 这个数字工具有助于为年轻患者提供更好的代谢健康管理.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 数字健康干预措施 数字健康干预措施
- 代谢综合征管理 代谢综合征管理
背景情况:
- 患有1型糖尿病的青少年需要持续管理以控制代谢.
- 文化相关的工具可以增强参与和遵守治疗计划.
- 移动应用程序为提供健康教育和支持提供了一个可扩展的平台.
研究的目的:
- 评估文化适应的移动应用程序对1型糖尿病青少年代谢控制的影响.
- 评估研究参与者脂质谱和生活质量的变化.
- 为了确定文化定制应用程序在支持糖尿病自我管理方面的有效性.
主要方法:
- 一项为期3个月的研究,涉及23名患有1型糖尿病的儿科参与者.
- 使用了带有玻尿酸胰岛素计算器的移动应用程序,以及具有血糖指数 (GI) 颜色编码的文化特定食品清单.
- 干预前后进行了血液检查,以监测代谢标志物.
主要成果:
- 在脂质资料中观察到统计学上显著的改善,HDL水平上升,LDL和甘油三水平下降.
- 参与者报告说,他们的生活质量总体上有所提高.
- 在糖化血红蛋白水平上没有观察到统计学意义上的变化.
结论:
- 根据文化定制的移动应用程序显示了改善1型糖尿病青少年代谢健康标志物的潜力.
- 该应用程序的功能,包括文化相关的食物信息和玻鲁斯计算器,可能有助于更好的饮食选择和胰岛素管理.
- 需要进一步的研究来探索对血糖控制和更广泛的健康结果的长期影响.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:16Insulin: Dosing Regimen and Adverse Effects
157
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
157
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183